Seeing Is Believing
Currently out of the existing stock ratings of Fedor Shabalin, 16 are a BUY (94.12%), 1 are a HOLD (5.88%).
Analyst Fedor Shabalin, currently employed at B. RILEY, carries an average stock price target met ratio of 18.67% that have a potential upside of 17.74% achieved within 15 days.
Fedor Shabalin’s has documented 34 price targets and ratings displayed on 4 stocks. The coverage is on the Technology sector.
Most recent stock forecast was given on HSDT, Helius Medical Technologies at 22-Sep-2026.
Analyst best performing recommendations are on HSDT (HELIUS MEDICAL TECHNOLOGIES).
The best stock recommendation documented was for HSDT (HELIUS MEDICAL TECHNOLOGIES) at 8/17/2026. The price target of $2.5 was fulfilled within 32 days with a profit of $0.84 (50.6%) receiving and performance score of 15.81.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 16-Oct-2025
$5
$2.2 (78.57%)
$8
1 months 13 days ago
(24-Aug-2026)
0/4 (0%)
$2 (66.67%)
Buy Since 05-Jan-2018
$3
$-0.36 (-10.71%)
$3
2 years 6 days ago
(01-Oct-2024)
3/6 (50%)
$-24.75 (-89.19%)
579
Buy Since 20-Feb-2019
$75
$72.2 (2578.57%)
$200
3 years 1 months 29 days ago
(08-Aug-2023)
1/2 (50%)
$5.75 (8.30%)
702
Buy Since 24-Jun-2021
$75
$72.2 (2578.57%)
$125
3 years 5 months 3 days ago
(04-May-2023)
0/5 (0%)
$21 (38.89%)
Buy Since 18-Mar-2016
$18
$15.2 (542.86%)
$200
3 years 7 months 22 days ago
(15-Feb-2023)
3/13 (23.08%)
$-56.25 (-75.76%)
422
Which stock is Fedor Shabalin most bullish on?
Which stock is Fedor Shabalin most reserved on?
What Year was the first public recommendation made by Fedor Shabalin?